Clinical Trial Update: Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer [NA]

View source ↗

Summary

This clinical trial investigates using patient-derived organoids to guide drug selection for patients with drug-resistant recurrent non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Non-small Cell Lung Cancer | NA | Status: RECRUITING